# US 2022/0033865 A1 · Method of Producing Lipid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033865 A1
- Document ID: US20220033865A1
- Status: Published application
- Kind: A1
- Application number: 17/278,805
- Filed: 2019-09-27
- Published: 2022-02-03
- Earliest claimed: 2018-10-01
- Assignees: Kao Corporation
- Applicants: Kao Corporation
- Inventors: Tatsuro OZAKI
- Web page: https://patentgrep.com/patent/US20220033865A1

## CPC

- C12P 7/6409: Fatty acids
- A01G 33/00: Cultivation of seaweed {or algae}
- A01H 13/00: Algae (unicellular algae C12N1/12)
- C12N 1/12: Unicellular algae; Culture media therefor (as new plants A01H13/00)
- C12N 9/0051: {acting on a sulfur group of donors (1.8)}
- C12N 15/82: for plant cells {, e.g. plant artificial chromosomes (PACs)}
- C12P 7/6463: obtained from glyceride producing microorganisms, e.g. single cell oil
- C12R 2001/89: Algae {; Processes using algae}
- Y02A 40/80: in fisheries management
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A01G: HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING (picking of fruits, vegetables, hops or the like A01D46/00; propagating unicellular algae C12N1/12)
- A01H: NEW PLANTS OR {NON-TRANSGENIC} PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A method of producing lipids, containing the steps of: culturing an alga in which expression of a gene encoding a protein containing a thioredoxin domain and a thioredoxin reductase domain is enhanced, and producing fatty acids or lipids containing the same as components.

## Claims

### Claim 1

A method of producing lipids, comprising the steps of:
introducing a gene encoding a protein containing a thioredoxin domain and a thioredoxin reductase domain into an algal host to enhance expression of the gene,
culturing the algal host,
and
producing fatty acids or lipids containing the same as components.

### Claim 2

A method of improving lipid productivity, comprising
introducing a gene encoding a protein containing a thioredoxin domain and a thioredoxin reductase domain into an algal host to enhance expression of the gene, thereby improving the amount of total fatty acids produced in a cell of the algal host.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the alga is an alga belonging to the genus Nannochloropsis.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the thioredoxin domain is a domain consisting of the following amino acid sequence (A) or (B), or the following amino acid sequence (C) or (D), and the thioredoxin reductase domain is a domain consisting of the following amino acid sequence (E) or (F), or the following amino acid sequence (G) or (H):
(A) the amino acid sequence at positions 529 to 629 of the amino acid sequence set forth in SEQ ID NO: 1;
(B) an amino acid sequence having 60% or more identity with the amino acid sequence (A), and constituting the thioredoxin domain having thioredoxin activity;
(C) the amino acid sequence at positions 525 to 625 of the amino acid sequence set forth in SEQ ID NO: 3;
(D) an amino acid sequence having 60% or more identity with the amino acid sequence (C), and constituting the thioredoxin domain having thioredoxin activity;
(E) the amino acid sequence at positions 137 to 448 of the amino acid sequence set forth in SEQ ID NO: 1;
(F) an amino acid sequence having 60% or more identity with the amino acid sequence (E), and constituting the thioredoxin reductase domain having thioredoxin reductase activity;
(G) the amino acid sequence at positions 134 to 445 of the amino acid sequence set forth in SEQ ID NO: 3; and
(H) an amino acid sequence having 60% or more identity with the amino acid sequence (G), and constituting the thioredoxin reductase domain having thioredoxin reductase activity.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the protein having the thioredoxin domain and the thioredoxin reductase domain is any one of the proteins selected from the group consisting of the following proteins (I) to (L):
(I) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1;
(J) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (I), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity;
(K) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 3; and
(L) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (K), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity.

### Claim 6 (depends on 1)

The method according to claim 1, wherein expression of one kind or two or more kinds of proteins involved in triacylglycerol synthetic pathway, fatty acid synthetic pathway, or Calvin-Benson-Bassham cycle is enhanced.

### Claim 7 (depends on 1)

The method according to claim 1, wherein expression of the following protein (O) or (P), any one selected from the group consisting of the following proteins (Q) to (T), the following protein (M) or (N), the following protein (U) or (V), the following protein (W) or (X), and the following protein (Y) or (Z) is enhanced:
(M) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 37;
(N) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (M), and having acyl-ACP thioesterase activity;
(O) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 35;
(P) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (O), and having acyl-CoA synthetase activity;
(Q) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 33;
(R) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Q), and having acyltransferase activity;
(S) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 76;
(T) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (S), and having acyltransferase activity;
(U) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 27;
(V) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (U), and having transketolase activity;
(W) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 29;
(X) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (W), and having fructose-1,6-bisphosphate aldolase activity;
(Y) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 31; and
(Z) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Y), and having ribose-5-phosphate isomerase activity.

### Claim 8

(canceled)

### Claim 9

A transformant of an alga, wherein the transformant comprises a gene encoding a protein containing a thioredoxin domain and a thioredoxin reductase domain that has been introduced into the transformant, thereby enhancing expression of the gene in the transformant.

### Claim 10 (depends on 9)

The transformant according to claim 9, wherein the alga is an alga belonging to the genus Nannochloropsis.

### Claim 11 (depends on 9)

The transformant according to claim 9, wherein the thioredoxin domain is a domain consisting of the following amino acid sequence (A) or (B), or the following amino acid sequence (C) or (D), and the thioredoxin reductase domain is a domain consisting of the following amino acid sequence (E) or (F), or the following amino acid sequence (G) or (H):
(A) the amino acid sequence at positions 529 to 629 of the amino acid sequence set forth in SEQ ID NO: 1;
(B) an amino acid sequence having 60% or more identity with the amino acid sequence (A), and constituting the thioredoxin domain having thioredoxin activity;
(C) the amino acid sequence at positions 525 to 625 of the amino acid sequence set forth in SEQ ID NO: 3;
(D) an amino acid sequence having 60% or more identity with the amino acid sequence (C), and constituting the thioredoxin domain having thioredoxin activity;
(E) the amino acid sequence at positions 137 to 448 of the amino acid sequence set forth in SEQ ID NO: 1;
(F) an amino acid sequence having 60% or more identity with the amino acid sequence (E), and constituting the thioredoxin reductase domain having thioredoxin reductase activity;
(G) the amino acid sequence at positions 134 to 445 of the amino acid sequence set forth in SEQ ID NO: 3; and
(H) an amino acid sequence having 60% or more identity with the amino acid sequence (G), and constituting the thioredoxin reductase domain having thioredoxin reductase activity.

### Claim 12 (depends on 9)

The transformant according to claim 9, wherein the protein having the thioredoxin domain and the thioredoxin reductase domain is any one of the proteins selected from the group consisting of the following proteins (I) to (L):
(I) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1;
(J) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (I), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity;
(K) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 3; and
(L) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (K), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity.

### Claim 13 (depends on 9)

The transformant according to claim 9, wherein expression of one kind or two or more kinds of proteins involved in triacylglycerol synthetic pathway, fatty acid synthetic pathway, or Calvin-Benson-Bassham cycle is enhanced.

### Claim 14 (depends on 9)

The transformant according to claim 9, wherein expression of the following protein (O) or (P), any one selected from the group consisting of the following proteins (Q) to (T), the following protein (M) or (N), the following protein (U) or (V), the following protein (W) or (X), and the following protein (Y) or (Z) is enhanced:
(M) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 37;
(N) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (M), and having acyl-ACP thioesterase activity;
(O) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 35;
(P) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (O), and having acyl-CoA synthetase activity;
(Q) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 33;
(R) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Q), and having acyltransferase activity;
(S) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 76;
(T) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (S), and having acyltransferase activity;
(U) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 27;
(V) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (U), and having transketolase activity;
(W) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 29;
(X) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (W), and having fructose-1,6-bisphosphate aldolase activity;
(Y) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 31; and
(Z) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Y), and having ribose-5-phosphate isomerase activity.

### Claim 15 (depends on 2)

The method according to claim 2, wherein the alga is an alga belonging to the genus Nannochloropsis.

### Claim 16 (depends on 2)

The method according to claim 2, wherein the thioredoxin domain is a domain consisting of the following amino acid sequence (A) or (B), or the following amino acid sequence (C) or (D), and the thioredoxin reductase domain is a domain consisting of the following amino acid sequence (E) or (F), or the following amino acid sequence (G) or (H):
(A) the amino acid sequence at positions 529 to 629 of the amino acid sequence set forth in SEQ ID NO: 1;
(B) an amino acid sequence having 60% or more identity with the amino acid sequence (A), and constituting the thioredoxin domain having thioredoxin activity;
(C) the amino acid sequence at positions 525 to 625 of the amino acid sequence set forth in SEQ ID NO: 3;
(D) an amino acid sequence having 60% or more identity with the amino acid sequence (C), and constituting the thioredoxin domain having thioredoxin activity;
(E) the amino acid sequence at positions 137 to 448 of the amino acid sequence set forth in SEQ ID NO: 1;
(F) an amino acid sequence having 60% or more identity with the amino acid sequence (E), and constituting the thioredoxin reductase domain having thioredoxin reductase activity;
(G) the amino acid sequence at positions 134 to 445 of the amino acid sequence set forth in SEQ ID NO: 3; and
(H) an amino acid sequence having 60% or more identity with the amino acid sequence (G), and constituting the thioredoxin reductase domain having thioredoxin reductase activity.

### Claim 17 (depends on 2)

The method according to claim 2, wherein the protein having the thioredoxin domain and the thioredoxin reductase domain is any one of the proteins selected from the group consisting of the following proteins (I) to (L):
(I) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1;
(J) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (I), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity;
(K) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 3; and
(L) a protein consisting of an amino acid sequence having 60% or more identity with the amino acid sequence of the protein (K), and containing the thioredoxin domain and the thioredoxin reductase domain having thioredoxin activity and thioredoxin reductase activity.

### Claim 18 (depends on 2)

The method according to claim 2, wherein expression of one kind or two or more kinds of proteins involved in triacylglycerol synthetic pathway, fatty acid synthetic pathway, or Calvin-Benson-Bassham cycle is enhanced.

### Claim 19 (depends on 2)

The method according to claim 2, wherein expression of the following protein (O) or (P), any one selected from the group consisting of the following proteins (Q) to (T), the following protein (M) or (N), the following protein (U) or (V), the following protein (W) or (X), and the following protein (Y) or (Z) is enhanced:
(M) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 37;
(N) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (M), and having acyl-ACP thioesterase activity;
(O) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 35;
(P) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (O), and having acyl-CoA synthetase activity;
(Q) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 33;
(R) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Q), and having acyltransferase activity;
(S) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 76;
(T) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (S), and having acyltransferase activity;
(U) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 27;
(V) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (U), and having transketolase activity;
(W) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 29;
(X) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (W), and having fructose-1,6-bisphosphate aldolase activity;
(Y) a protein consisting of the amino acid sequence set forth in SEQ ID NO: 31; and
(Z) a protein consisting of an amino acid sequence having 50% or more identity with the amino acid sequence of the protein (Y), and having ribose-5-phosphate isomerase activity.
